UCB's Global Corporate Website

Zampilimab - UCB7858

 

Back to the Clinical Study Index

 

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Chronic Allograft Injury A 2-Stage, Multicenter, Randomized, Placebo-Controlled Study to Evaluate Safety/Tolerability, Pharmacokinetics, and Efficacy of UCB7858 in Adult Kidney Transplant Recipients With Chronic Allograft Injury Phase 1 / 2 CAI001
Ongoing
2017-004807-31